Goldline Pharmaceutical Limited (BOM:544759)
India flag India · Delayed Price · Currency is INR
29.60
+0.33 (1.13%)
At close: Nov 16, 2026

Goldline Pharmaceutical Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.030.641.081.421.841.50
Debt / EBITDA Ratio
-1.301.802.564.496.05
Debt / FCF Ratio
-3.323.716.148.44-
Net Debt / Equity Ratio
-0.030.600.961.321.831.48
Net Debt / EBITDA Ratio
-1.211.592.384.465.97
Net Debt / FCF Ratio
-3.113.295.708.40-
Asset Turnover
-1.131.141.111.001.20
Inventory Turnover
-1.731.520.951.082.67
Quick Ratio
3.601.381.011.020.971.18
Current Ratio
5.422.151.981.921.872.37
Return on Equity (ROE)
-33.60%31.27%26.26%4.01%4.86%
Return on Assets (ROA)
-15.50%15.00%12.35%7.06%5.17%
Return on Invested Capital (ROIC)
-24.35%22.64%17.14%8.49%7.26%
Return on Capital Employed (ROCE)
-40.80%40.90%32.80%21.50%12.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Payout Ratio
-5.27%7.58%12.00%84.49%-
Buyback Yield / Dilution
-47.95%--14.95%-0.04%-0.09%0.49%